Recurrent Urinary Tract Infections: Uro-Vaxom®, a New Alternative

被引:15
作者
Cruz, Francisco [1 ]
Dambros, Miriam [2 ]
Naber, Kurt G. [3 ]
Bauer, Hartwig W. [4 ]
Cozma, Gabriel [5 ]
机构
[1] Hosp Sao Joao, Dept Urol, Oporto, Portugal
[2] Univ Estadual Campinas, UNICAMP, Div Urol, Sao Paulo, Brazil
[3] Tech Univ Munich, Sch Med, Munich, Germany
[4] Univ Munich, Dept Urol, Munich, Germany
[5] OM PHARMA, Geneva, Switzerland
关键词
Antibacterial agents; Cystitis; Immunostimulant; Microbial drug resistance; OM-89; Prophylaxis; Recurrence; Urinary tract infections; Uro-Vaxom; ESCHERICHIA-COLI EXTRACT; DOUBLE-BLIND; ORAL IMMUNOTHERAPY; OM-89; EPIDEMIOLOGY; PROPHYLAXIS; MULTICENTER; WOMEN;
D O I
10.1016/j.eursup.2009.07.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Context: Acute uncomplicated cystitis is generally treated with short-term antibiotic therapy. However, recurrence of lower urinary tract infections (UTIs) is very common, especially in premenopausal women. These recurrent infections considerably affect a patient's quality of life and have a huge financial and economic impact on society. Therefore, prevention of UTI recurrence is highly important. Objective: To provide an overview of the state of the art and the current controversies on the prophylaxis of recurrent UTIs. Evidence acquisition: This manuscript is based on presentations given at a satellite symposium held at the 2nd World Congress on Controversies in Urology (CURy) in Lisbon, Portugal. Data were retrieved from recent review papers, original papers, and abstracts on recurrent UTIs. Evidence synthesis: Currently, antibiotic prophylaxis is recommended as a first-line strategy for the prevention of recurrent UTIs in the European Association of Urology guidelines. However, more and more uropathogens become resistant to certain types of antimicrobials. Hence, alternative prophylactic strategies are gaining importance. Oral administration of immunoactive Escherichia coli (E. coli) fractions (Uro-Vaxom (R)) is one of these methods. Our understanding of its mechanism of action has considerably grown over the past 20 yr. In several double-blind, placebo-controlled studies, oral immunostimulation with E. coli extracts significantly reduced recurrent UTIs compared with placebo. Moreover, this strategy was well tolerated. Two new Uro-Vaxom studies have been initiated to gather more data on the long-term efficacy, the treatment regimen, and the mechanism of action of this immunostimulant and to find broader indications for this therapy. Conclusions: Although scientific and clinical data on oral immunostimulation with E. coli fractions have increased significantly, more studies are needed to provide convincing evidence that this strategy is equally effective as antibiotic prophylaxis for the prevention of recurrent cystitis. (C) 2009 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:762 / 768
页数:7
相关论文
共 50 条
  • [41] Recurrent urinary tract infections in females
    Mohsin, Raheela
    Siddiqui, Khurram Mutahir
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2010, 60 (01) : 55 - 59
  • [42] Recurrent urinary tract infections in adults: a practical guide
    Hughes, Thomas
    Juliebo-Jones, Patrick
    Saada, Louis
    Saeed, Kordo
    Somani, Bhaskar K.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2021, 82 (12)
  • [43] Recurrent uncomplicated lower urinary tract infections in women
    Liu, Jiaxin
    Xu, Kaiyun
    Hu, Jiajie
    Wang, Lei
    Liu, Zhiyong
    CURRENT UROLOGY, 2025, 19 (02) : 90 - 94
  • [44] Recurrent urinary tract infections in psychotic mood disorders
    Paletta, Nina J.
    Wang, Alexandre K.
    Miller, Brian J.
    SCHIZOPHRENIA RESEARCH, 2017, 184 : 137 - 138
  • [45] Multidrug-resistant Uro-associated Escherichia coli Populations and Recurrent Urinary Tract Infections in Patients Performing Clean Intermittent Self-catheterisation
    Mowbray, Catherine
    Tan, Aaron
    Vallee, Maxime
    Fisher, Holly
    Chadwick, Thomas
    Brennand, Catherine
    Walton, Katherine E.
    Pickard, Robert S.
    Harding, Christopher
    Aldridge, Phillip D.
    Hall, Judith
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 37 : 90 - 98
  • [46] The use of intravesical gentamicin to treat recurrent urinary tract infections in lower urinary tract dysfunction
    Abrams, Paul
    Hashim, Hashim
    Tomson, Charles
    Macgowan, Alasdair
    Skews, Rachel
    Warren, Katherine
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 (08) : 2109 - 2116
  • [47] Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline
    Anger, Jennifer
    Lee, Una
    Ackerman, A. Lenore
    Chou, Roger
    Chughtai, Bilal
    Clemens, J. Quentin
    Hickling, Duane
    Kapoor, Anil
    Kenton, Kimberly S.
    Kaufman, Melissa R.
    Rondanina, Mary Ann
    Stapleton, Ann
    Stothers, Lynn
    Chai, Toby C.
    JOURNAL OF UROLOGY, 2019, 202 (02) : 282 - 289
  • [48] Diagnosis and management of recurrent urinary tract infections in non-pregnant women
    Gupta, Kalpana
    Trautner, Barbara W.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 346
  • [49] D-MannosE to prevent Recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial
    Franssen, Marloes
    Cook, Johanna
    Robinson, Jared
    Williams, Nicola
    Glogowska, Margaret
    Yang, Yaling
    Allen, Julie
    Butler, Christopher C.
    Thomas, Nick
    Hay, Alastair
    Moore, Michael
    Hayward, Gail
    BMJ OPEN, 2021, 11 (01):
  • [50] Effect and Analysis of Bacterial Lysates for the Treatment of Recurrent Urinary Tract Infections in Adults
    Ahumada-Cota, Ricardo E.
    Hernandez-Chinas, Ulises
    Milian-Suazo, Feliciano
    Chavez-Berrocal, Maria E.
    Navarro-Ocana, Armando
    Martinez-Gomez, Daniel
    Patino-Lopez, Genaro
    Salazar-Jimenez, Erika P.
    Eslava, Carlos A.
    PATHOGENS, 2020, 9 (02):